HBV Citations List: March 2025

Literature Citations

1. Design, Synthesis, and Bioevaluation of Matrine Derivatives as Potential Anti-Hepatitis B Virus Agents. Liu, T.T., M.F. Xie, X. Liu, R.T. Li, Y. Bai and Z.J. Zhang. Biomolecules, 2025. 15(3): 436. PMID[40149972]. PMCID[PMC11940400].
[PubMed]. HBV_03_2025.

2. Design and biochemical evaluation of 2-cyclopropyl-thioureidobenzamide (CP-TBA) derivatives as potent HBV capsid assembly modulators targeting a novel binding site. Wang, M., Y.T. Dou, A.X. Li, Z.C. Yang, M.H. Liang, Y.Y. Liu, Y. Xie, L.Y. Wang, Y.Q. Cai, Y.F. Chen, P. Xue, X. Wang, Z.C. Wu, P. Zhan and H.Y. Jia. European Journal of Medicinal Chemistry, 2025. 289: 117441. PMID[40043535].
[PubMed]. HBV_03_2025.

Patent Citations

This month, no relevant HBV patents were identified.